Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1999 Mar-Jun;72(2-3):203–209.

Management of gastroesophageal reflux disease: the primary care strategy.

R Jones 1
PMCID: PMC2579015  PMID: 10780582

Abstract

Gastroesophageal reflux disease (GERD) is a common problem in the community and in general practice. General practitioners and family physicians need to understand patients' reasons for consultation and also be aware of alarm symptoms suggestive of serious disease. A primary care management strategy for GERD is proposed, in which the place of endoscopic and other investigations is defined, the role of lifestyle modification discussed, and recommendations for longer-term therapy and management are made.

Full text

PDF
203

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agréus L., Svärdsudd K., Nyrén O., Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995 Sep;109(3):671–680. doi: 10.1016/0016-5085(95)90373-9. [DOI] [PubMed] [Google Scholar]
  2. Blair D. I., Kaplan B., Spiegler J. Patient characteristics and lifestyle recommendations in the treatment of gastroesophageal reflux disease. J Fam Pract. 1997 Mar;44(3):266–272. [PubMed] [Google Scholar]
  3. Corder A. P., Jones R. H., Sadler G. H., Daniels P., Johnson C. D. Heartburn, oesophagitis and Barrett's oesophagus in self-medicating patients in general practice. Br J Clin Pract. 1996 Jul-Aug;50(5):245–248. [PubMed] [Google Scholar]
  4. Dent J. Long-term aims of treatment of reflux disease, and the role of non-drug measures. Digestion. 1992;51 (Suppl 1):30–34. doi: 10.1159/000200912. [DOI] [PubMed] [Google Scholar]
  5. Heudebert G. R., Marks R., Wilcox C. M., Centor R. M. Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis. Gastroenterology. 1997 Apr;112(4):1078–1086. doi: 10.1016/s0016-5085(97)70118-5. [DOI] [PubMed] [Google Scholar]
  6. Hillman A. L., Bloom B. S., Fendrick A. M., Schwartz J. S. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. Arch Intern Med. 1992 Jul;152(7):1467–1472. [PubMed] [Google Scholar]
  7. Jones R., Lydeard S. Dyspepsia in the community: a follow-up study. Br J Clin Pract. 1992 Summer;46(2):95–97. [PubMed] [Google Scholar]
  8. Jones R., Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ. 1989 Jan 7;298(6665):30–32. doi: 10.1136/bmj.298.6665.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Klauser A. G., Schindlbeck N. E., Müller-Lissner S. A. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990 Jan 27;335(8683):205–208. doi: 10.1016/0140-6736(90)90287-f. [DOI] [PubMed] [Google Scholar]
  10. Lydeard S., Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract. 1989 Dec;39(329):495–498. [PMC free article] [PubMed] [Google Scholar]
  11. Schindlbeck N. E., Klauser A. G., Voderholzer W. A., Müller-Lissner S. A. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med. 1995 Sep 11;155(16):1808–1812. [PubMed] [Google Scholar]
  12. Talley N. J., Zinsmeister A. R., Schleck C. D., Melton L. J., 3rd Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992 Apr;102(4 Pt 1):1259–1268. [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES